Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Syra Health Corp reported Q4 2025 results: net income ($135K), EPS ($0.01).
- Period
- Q4 2025
- Net income
- ($135K)
- EPS
- ($0.01)
- Result
- reported results
Exact text from the filing
Q4 and Full Year 2025 Financial Highlights ● Population Health revenue grew 157% year-over-year to $5.3 million in FY2025 from $2.1 million in FY2024, driven by demand for the Company's higher margin yielding population health solutions, including data analytics, health education and training. Q4 2025 Population Health revenue grew 128% year-over-year to $1.3 million, compared to $550K in Q4 2024. ● Earnings per share improved by $0.42 in FY2025 to ($0.08) from ($0.50) in FY2024. Q4 2025 EPS improved to ($0.01) from ($0.08) in Q42024, representing meaningful progress as the Company moves closer to profitability. ● Total operating expenses declined 37% to $3.4 million in FY2025 when compared to $5.4 million in FY2024. Q4 2025 operating expenses decreased 13% to $727K from $836K in Q4 2024. ● Net loss improved 76% to ($896K) in FY2025 from ($3.8M) in FY2024. Q4 2025 net loss was reduced 73% to ($135K) versus ($504K) in Q4 2024, reflecting a significantly improved cost structure. ● Gross
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Syra Health Corp reported FY2025 results: revenue $7,225,973, net income ($896,333), EPS ($0.08).
- Period
- FY2025
- Revenue
- $7,225,973
- Net income
- ($896,333)
- EPS
- ($0.08)
- Result
- reported results
Exact text from the filing
Syra Health Corp Statements of Operations For the Years Ended December 31, 2025 and 2024 December revenues $ 7,225,973 $ 7,982,082 Cost of services 4,738,211 6,329,119 Gross profit 2,487,762 1,652,963 OPERATING EXPENSES: Salaries and benefits 1,500,688 2,718,743 Professional services 737,714 606,051 Research and development expenses 67,840 585,146 Selling, general and administrative expenses 1,065,376 1,445,170 Depreciation 20,468 62,738 Total operating expenses 3,392,086 5,417,848 Net loss from operations (904,324 ) (3,764,885 ) OTHER INCOME (EXPENSES): Interest income 21,261 21,247 Interest expense (13,270 ) (15,600 ) Total other income (expense) 7,991 5,647 NET INCOME (LOSS) $ (896,333 ) $ (3,759,238 ) Loss per common share, basic and diluted $ (0.08 ) $ (0.50 ) Weighted average number of common shares outstanding, basic and diluted 11,852,347 7,551,576
View on SEC.gov